SCHEMBL17184372

SCHEMBL17184372

Fc1ccc(-c2nc3c[c]ccc3nc2-c2ccc(F)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 12/20 0.51
MAPK10 P53779 2/20 0.51
ADORA2A P29274 2/20 0.37
KDM4E B2RXH2 2/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ERBB2 P04626 1/20 0.35
ADORA1 P30542 1/20 0.35
DHODH Q02127 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15987437 0.81 KDM4E (0.50) KDM4ELMNAGAAL3MBTL1TDP1
SCHEMBL5885440 0.77 ALDH1A1 (0.60) MAPK14ADORA2AKDM4ELMNAL3MBTL1
SCHEMBL71619 0.76 MAPK14 (0.81) MAPK14MAPK10ADORA2AKDM4ELMNA
SCHEMBL29405271 0.76 MAPK14 (0.81) MAPK14MAPK10ADORA2AKDM4ELMNA
SCHEMBL29596631 0.74 MAPK14 (0.78) MAPK14MAPK10ADORA2AKDM4ELMNA
SCHEMBL27962380 0.74 MAPK14 (0.78) MAPK14MAPK10ADORA2AKDM4ELMNA
SCHEMBL29767839 0.74 MAPK14 (0.78) MAPK14MAPK10ADORA2AKDM4ELMNA
SCHEMBL28252524 0.74 MAPK14 (0.78) MAPK14MAPK10ADORA2AKDM4ELMNA
SCHEMBL31070210 0.72 KDM4E (0.64) MAPK14MAPK10KDM4EL3MBTL1KMT2A
SCHEMBL1302945 0.72 MAPK14 (0.58) MAPK14MAPK10KDM4EGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3131881-A1 QUINOXALINE COMPOUNDS AND USES THEREOF Millennium Pharmaceuticals, Inc. (US) 2017-02-22 EP disclosed
WO-2015161142-A1 QUINOXALINE COMPOUNDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-10-22 WO disclosed